Zadnji put ažurirano :
19/11/2024
antibiotik   Teicoplanine  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Bactomax Brazil
Celplanin Indija, Austrija, Peru
Heptacidin Meksiko
Koplan Brazil
Pitil Čile
Plavital Meksiko
Sinbaken Meksiko
Targocid Argentina, Australija, Austrija, Belgija, Brazil, Čile, Danska, Egipat, Finska, Francuska, Grčka, Hrvatska, Iran, Irska, Kolumbija, Luksemburg, Madžarska, Malezija, Maroko, Meksiko, Nizozemska, Norveška, novi Zeland, Poljska, Portugal, Slovenija, Španjolska, Švedska, Švicarska, Tajland, Tunis, Turska, Ujedinjeni Arapski Emirati, Velika Britanija
Targosid Italija, Portugal
Teicoplanin Iran, Njemačka
Teicoplanina Čile, Meksiko, Španjolska
Teicox Argentina
Tekosit Turska
Tepladex Meksiko
Teriplax Meksiko
Ticocin Venecuela
Zicoplanin Indija
Bibliografija   injekcija   Bibliografija : Teicoplanine  
Vrsta Publikacija
289 Časopis Jim LK.
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Ann Pharmacotherapy 1993 ; 27: 704-707.
1608 Časopis Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.
Assessment of the stability of teicoplanin in intravenous infusions.
Int J Pharm Compound 2001 ; 5: 397-400.
2057 Časopis Droste JC, Jeraj HA, MacDonald A, Farrington K.
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
J Antimicrob Chemother 2003 ; 51: 849-855.
2450 Časopis Manduru M, Fariello A, White RL, Fox JL, Bosso JA.
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.
3656 Laboratorija Teicoplanine (Targocid®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2014
3728 Časopis Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3976 Časopis Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4440 Časopis Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Ann Nutr Metab 2018 ; 73: 227-233.
4444 Časopis Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P.
Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics.
Clinical Nutrition 1999 ; 19, 3: 159-165.

  Mentions Légales